We are live on
!
Find out more
SCG
Social Capital Group Portfolio holdings
AUM
$5.16M
1-Year Est. Return
66.85%
This Quarter
Est. Return
-23.98%
1 Year Est. Return
-66.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
–
Cap. Flow
+$160M
Cap. Flow
% of AUM
136.84%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProKidney
PROK
|
+$127M |
| 2 |
AKLI
Akili Inc
AKLI
|
+$20.9M |
| 3 |
DNAB
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
|
+$6.36M |
| 4 |
DNAD
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
|
+$6.36M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.02% |
| 2 | Financials | 10.98% |
Similar funds
TM
APGC
APA
AI
KSCM
SP
EL
T
Social Capital Group's Q4 2022 Portfolio in Review
Q4 2022 is the first quarter with a 13F filing on record for Social Capital Group, which disclosed 4 positions worth $117M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is ProKidney: 13,273,000 shares worth $91.1M.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, followed by Financials.
- Social Capital Group's largest Q4 2022 buy was ProKidney: 13,273,000 shares worth $91.1M.
- Social Capital Group's ten largest holdings make up 100% of its $117M portfolio in Q4 2022.
- Social Capital Group disclosed 4 positions in Q4 2022, its first 13F filing on record.
Based on Social Capital Group's 13F filing for Q4 2022, filed 13 Feb 2023.